MENU
BCYC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Bicycle Therapeutics (BCYC) Earnings Date & Reports

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles... Show more

A.I. Advisor
published Earnings

BCYC is expected to report earnings to rise 11.89% to -95 cents per share on March 03

Bicycle Therapeutics BCYC Stock Earnings Reports
Q4'25
Est.
$-0.95
Q3'25
Beat
by $0.23
Q2'25
Missed
by $0.20
Q1'25
Missed
by $0.03
Q4'24
Beat
by $0.11
The last earnings report on October 30 showed earnings per share of -85 cents, beating the estimate of -108 cents. With 218.23K shares outstanding, the current market capitalization sits at 454.36M.
View a ticker or compare two or three
BCYC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BCYC showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a holding company, which engages in the development of biopharmaceuticals.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Granta Park, Great Abington
Phone
+44 1223261503
Employees
284
Web
https://www.bicycletherapeutics.com